Document is current
Any future updates will be listed below
-
Authors
Krawetz, Roman J. https://orcid.org/0000-0002-2576-4504
Abubacker, Saleem
Leonard, Catherine
Masson, Anand O.
Shah, Sophia
Narendran, Nadia
Tailor, Pankaj
Regmi, Suresh C.
Labit, Elodie https://orcid.org/0000-0002-7659-6248
Ninkovic, Nicoletta
Corpuz, Jessica May
Ito, Kenichi
Underhill, T. Michael https://orcid.org/0000-0003-3048-9102
Salo, Paul T. https://orcid.org/0000-0002-4005-9758
Schmidt, Tannin A.
Biernaskie, Jeff A.
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (RGPIN-2014-04586)
Canada Foundation for Innovation (JELF)
Calgary Foundation (Grace Glaum Professorship)
Gouvernement du Canada | Canadian Institutes of Health Research (01309MOP-311542-DIB-CBBA-170939)
UCalgary | Cumming School of Medicine, University of Calgary (PDF award)
- License Information
-
More Information
Article History
Received: 15 July 2021
Accepted: 20 May 2022
First Online: 24 June 2022
Competing interests
: S.A., T.A.S., J.A.B., and R.J.K., have authored patents related to rhPRG4, and T.A.S. hold equity in Lubris BioPharma LLC. T.A.S. is also a paid consultant for Lubris BioPharma, Authors declare that they have no competing interests in additional to those listed above.
